Publications
Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay : Brighton Adverse Drug Reactions Risk (BADRI) model Ghent University
Drug interactions and adverse drug reactions in the older patients admitted to the emergency department Ghent University
The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort : trial protocol Ghent University
Drug interactions and adverse drug reactions in the elderly admitted to the emergency department of ghent university hospital Ghent University
Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech Republic Vrije Universiteit Brussel
Background Oral anticoagulants are established drugs of choice for the prevention and treatment of thromboembolic events. However, monitoring their safety remains warranted. Objective The aim was to analyze spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech Republic. Setting Retrospective observational pharmacovigilance study. Methods Adverse drug reaction reports were obtained from the State Institute ...
Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study KU Leuven
An Artificial Intelligence Approach to Support Detection of Neonatal Adverse Drug Reactions Based on Severity and Probability Scores: A New Risk Score as Web-Tool KU Leuven
Incident adverse drug reactions in geriatric inpatients : a multicentred observational study Ghent University
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis Vrije Universiteit Brussel
OBJECTIVES: This analysis aims to calculate MTX monotherapy persistence and describe the occurrence of and factors associated with the occurrence of adverse drug reactions (ADRs) with MTX.
METHODS: Patients with JIA starting MTX monotherapy from two UK studies were included. Patient characteristics, treatment details and ADR occurrence were collected at treatment start, 6 months, 1 year and annually. The following groups of ADRs were ...